Predictors of cladribine effectiveness in multiple sclerosis: a real-world, multicenter, two-year follow-up study

被引：0
|
作者：
Petracca, M. [1 ]
Ruggieri, S. [1 ,2 ]
Barbuti, E. [3 ]
Ianniello, A. [1 ]
Fantozzi, R. [4 ]
Di Lemme, S. [4 ]
Maniscalco, G. [5 ]
Landi, D. [6 ]
Marfia, G. [6 ]
Di Gregorio, M. [7 ]
Iodice, R. [8 ,9 ]
Sinisi, L. [10 ]
Missione, R. [11 ]
Coppola, C. [11 ]
Bonavita, S. [11 ]
Borriello, G.
Lus, G. [11 ]
Pozzilli, C. [1 ]
Signoriello, E. [11 ]
机构：
[1] Sapienza Univ, Dept Human Neurosci, Rome, Italy
[2] Sapienza Univ, MS Ctr, S Andrea Hosp, Rome, Italy
[3] IRCCS Neuromed, Neurol Unit, Pozzilli, Italy
[4] A Cardarelli Hosp, Multiple Sclerosis Ctr, Naples, Italy
[5] Tor Vergata Univ, Dept Syst Med, Multiple Sclerosis Clin & Res Unit, Rome, Italy
[6] Azienda Osped Univ San Giovanni Dio & Ruggi Arago, Salerno, Italy
[7] Univ Naples Federico II, Dept Neurosci Reprod Sci & Odontostomatol, Naples, Italy
[8] San Paolo Hosp, Div Neurol, Naples, Italy
[9] San Paolo Hosp, MS Ctr, Naples, Italy
[10] Univ Campania Luigi Vanvitelli, Multiple Sclerosis Ctr, Div Neurol 2, Dept Adv Med & Surg Sci, Naples, Italy
[11] San Pietro Fatebenefratelli Hosp, MS Ctr, Neurol Unit, Rome, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2022年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-642
引用
收藏
页码：787 / 787
页数：1
相关论文
共 50 条
  • [21] Real-world data on alemtuzumab treatment of relapsing multiple sclerosis: a two-year prospective one center study
    Sandgren, S.
    Novakova, L.
    Axelsson, M.
    Lycke, J.
    Malmestrom, C.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 902 - 903
  • [22] Two-year follow-up of the pivotal multicenter trials of sirolimus.
    Kahan, BD
    TRANSPLANTATION, 2000, 69 (08) : S361 - S361
  • [23] Cognition in LND: A two-year follow-up study
    Solan, A
    Matthews, W
    Barabas, G
    Robey, K
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 1997, 39 (07): : 492 - 493
  • [24] Two-year follow-up results of the SPACE study
    Forbes, Thomas L.
    JOURNAL OF VASCULAR SURGERY, 2009, 49 (06) : 1617 - 1617
  • [25] A two-year follow-up study: multiple sclerosis functional composite versus expanded disability status scale
    Alvarez-Lafuente, R.
    Garcia-Montojo, M.
    De Las Heras, V.
    Dominguez-Mozo, M. I.
    Bartolome, M.
    Garcia-Martinez, A.
    Arroyo, R.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S55 - S56
  • [26] Two-year follow-up study assessing cortical and deep gray matter loss in benign multiple sclerosis
    Ruet, A.
    Bendfeldt, K.
    Sprenger, T.
    Versteeg, A.
    Magon, S.
    Naegelin, Y.
    Klieverik-Sombekke, M. H.
    Kappos, L.
    Radue, E-W
    Uitdehaag, B. M. J.
    Barkhof, F.
    Vrenken, H.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 46 - 46
  • [27] Real world evidence for cladribine and fingolimod: comparative effectiveness study after 2 years of follow-up
    Mulero, P.
    Gonzalez, I.
    Caminero, A. B.
    Chavarria-Miranda, A.
    Alvarez-Rodriguez, E.
    Yugueros, I.
    Garea, M. J.
    Mendoza, A.
    Villa, R.
    Munoz, M. F.
    Gonzalez, T.
    Perez, D.
    Tola, M. A.
    El Berdei, Y.
    Tellez, N.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 668 - 669
  • [28] The brief international cognitive assessment in multiple sclerosis: preliminary results from a two-year follow-up study
    McNicholas, N.
    O'Connell, K.
    Tubridy, N.
    Hutchinson, M.
    McGuigan, C.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 572 - 573
  • [29] Two-year follow-up of regulatory B cells following alemtuzumab in multiple sclerosis patients
    Kim, Y.
    Kim, G.
    Shin, H. -J.
    Hyun, J. -W.
    Kim, S. -H.
    Kim, H. J.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 464 - 464
  • [30] Cladribine use in multiple sclerosis: a monocentric real-world experience
    Pilotto, Silvy
    Mellino, Paolo
    Carmagnini, Daniele
    Frau, Jessica
    Coghe, Giancarlo
    Cocco, Eleonora
    Lorefice, Lorena
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 639 - 640
12345